Now includes separate tube of DTT
Most eukaryotic mRNAs require a 7-methyl guanosine (m7G) cap structure at the 5´-end and a poly(A) tail at the 3′-end for efficient translation. The HiScribe T7 mRNA Kit with CleanCap Reagent AG utilizes an optimized RNA synthesis formulation and trinucleotide cap analog technology for co-transcriptionally capping mRNAs that contain a natural Cap-1 structure in a single simplified reaction without compromising RNA yield. By using a DNA template with a T7 promoter sequence followed by an AG initiation sequence and an encoded poly(A) tail, mRNAs can be transcribed with a 5´-m7G Cap-1 structure that is polyadenylated, translationally competent and able to evade the cellular innate immune response.
The HiScribe T7 mRNA Kit with CleanCap Reagent AG is formatted with individual vials of NTPs and CleanCap Reagent AG to allow for partial or complete substitution of modified NTPs, with a total kit yield of 1.8 mg of mRNA. Cap-1 mRNA synthesized from this kit is suitable for many applications, including transfections, microinjections, in vitro translation, preclinical mRNA therapeutic mRNA studies as well as RNA structure and function analysis.
This kit contains sufficient reagents for 20 reactions (20 µl each). Each standard reaction yields ≥ 90 µg of RNA from 1 µg CLuc AG Control Template DNA. Each kit can yield ≥ 1.8 mg RNA.
The following reagents are supplied with this product:
NEB # | Component Name | Component # | Stored at (°C) | Amount | Concentration |
E2080S | -20 |
T7 RNA Polymerase Mix | M0255AAVIAL | -20 | 1 x 0.04 ml | ||
LiCl Solution | B2051AVIAL | -20 | 1 x 1.4 ml | ||
DNase I (RNase-free) | M0303AAVIAL | -20 | 1 x 0.04 ml | 2,000 units/ml | |
CLuc AG Control Template | N2078AVIAL | -20 | 1 x 0.02 ml | 0.25 mg/ml | |
10X T7 CleanCap® Reagent AG Reaction Buffer | B2082AVIAL | -20 | 1 x 0.04 ml | ||
CleanCap® Reagent AG | S1413AVIAL | -20 | 1 x 0.04 ml | 40 mM | |
ATP | N0489AVIAL | -20 | 1 x 0.04 ml | 60 mM | |
GTP | N0490AVIAL | -20 | 1 x 0.04 ml | 50 mM | |
CTP | N0491AVIAL | -20 | 1 x 0.04 ml | 50 mM | |
UTP | N0492AVIAL | -20 | 1 x 0.04 ml | 50 mM | |
Dithiothreitol (DTT) | B1222AVIAL | -20 | 1 x 0.5 ml | 100 mM |
E2080L | -20 |
T7 RNA Polymerase Mix | M0255AVIAL | -20 | 2 x 0.1 ml | ||
LiCl Solution | B2051AVIAL | -20 | 2 x 1.4 ml | ||
CLuc AG Control Template | N2078AVIAL | -20 | 1 x 0.02 ml | 0.25 mg/ml | |
DNase I (RNase-free) | M0303AVIAL | -20 | 2 x 0.1 ml | 2,000 units/ml | |
Dithiothreitol (DTT) | B1222AVIAL | -20 | 1 x 0.5 ml | 100 mM | |
10X T7 CleanCap® Reagent AG Reaction Buffer | B2082AAVIAL | -20 | 1 x 0.2 ml | ||
ATP | N0489AAVIAL | -20 | 1 x 0.2 ml | 60 mM | |
GTP | N0490AAVIAL | -20 | 1 x 0.2 ml | 50 mM | |
CTP | N0491AAVIAL | -20 | 1 x 0.2 ml | 50 mM | |
UTP | N0492AAVIAL | -20 | 1 x 0.2 ml | 50 mM | |
CleanCap® Reagent AG | S1413AAVIAL | -20 | 1 x 0.2 ml | 40 mM |
1Final capping is dependent upon the CleanCap Reagent, DNA template and final mRNA sequence. Secondary structure due to RNA length and base composition can affect final capping efficiency.
Products and content are covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB). The use of trademark symbols does not necessarily indicate that the name is trademarked in the country where it is being read; it indicates where the content was originally developed. The use of this product may require the buyer to obtain additional third-party intellectual property rights for certain applications. For more information, please email busdev@neb.com.
This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
New England Biolabs (NEB) is committed to practicing ethical science – we believe it is our job as researchers to ask the important questions that when answered will help preserve our quality of life and the world that we live in. However, this research should always be done in safe and ethical manner. Learn more.CleanCap® and products incorporating it are sold under license from TriLink BioTechnologies, LLC and may be used for research use only, not for use in diagnostics, therapeutics procedures or for use in humans. For additional information, please see the product’s Limited Use License at https://www.trilinkbiotech.com/cleancap-research-license